B. Schlichtmann

Functionalized polyanhydride nanoparticles for improved treatment of mitochondrial dysfunction.

Matthew G. Panthani, B. Narasimhan, S. Mallapragada, 2021, Journal of biomedical materials research. Part B, Applied biomaterials.

Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice.

B. Narasimhan, Souvarish Sarkar, B. Kalyanaraman, 2017, Antioxidants & redox signaling.

Enzyme Immunoassay-Based Platform for Accurate Detection of Serum Pathological α-Synuclein in Parkinson's Disease Patients.

B. Narasimhan, S. Mallapragada, A. Kanthasamy, 2020, ACS chemical neuroscience.

Shifting the optimal stiffness for cell migration

Erkan Tüzel, Benjamin L Bangasser, David J Odde, 2017, Nature Communications.

Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers.

B. Narasimhan, S. Mallapragada, Benjamin W Schlichtmann, 2018, Nanoscale.

Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery.

H. Gendelman, B. Narasimhan, S. Mallapragada, 2018, Journal of biomedical materials research. Part A.

Ligand-cascading nano-delivery devices to enable multiscale targeting of anti-neurodegenerative therapeutics

Adam S Mullis, B. Narasimhan, S. Mallapragada, 2018, Biomedical materials.

Targeted nano-carriers to combat neurodegeneration

Benjamin W Schlichtmann, B. Schlichtmann, 2017 .

NANOTECHNOLOGY-MEDIATED THERAPEUTIC STRATEGIES AGAINST SYNUCLEINOPATHIES IN NEURODEGENERATIVE DISEASE.

B. Narasimhan, S. Mallapragada, A. Kanthasamy, 2021, Current opinion in chemical engineering.